← Back to Search

Mobile App Support for Opioid Use Disorder (MPS Trial)

N/A

Recruiting

Led By Megan Ranney, MD, MPH

Research Sponsored by Brown University

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Age ≥ 18 years old

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 6 months

Awards & highlights

MPS Trial Summary

This trial will test a mobile app-based peer support program to help people with opioid use disorders, who are especially vulnerable during the COVID-19 pandemic. The app could provide an accessible, personalized, and scalable way to improve recovery during this time.

Who is the study for?

This trial is for English-speaking adults over 18 who identify as being in recovery from or treatment for opioid use disorder (OUD) and own a smartphone. It's not open to those without an Android or iOS phone, anyone previously enrolled, individuals unable to consent, or people currently incarcerated.Check my eligibility

What is being tested?

The study tests a mobile app-based peer support program against usual care for OUD recovery. It aims to see if the app can boost recovery capital, keep patients in treatment longer, and lessen psychosocial stress during the COVID-19 pandemic.See study design

What are the potential side effects?

Since this trial involves a mobile app rather than medication, traditional side effects are not applicable. However, users may experience increased screen time which could lead to eye strain or sleep disturbances.

MPS Trial Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I am 18 years old or older.

MPS Trial Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 6 months

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~6 months

This trial's timeline: 3 weeks for screening, Varies for treatment, and 6 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Change in the Brief Assessment of Recovery Capital (BARC-10) score over 6 month study period

MPS Trial Design

2Treatment groups

Experimental Treatment

Active Control

Group I: Marigold APPExperimental Treatment1 Intervention

Participants randomized to receive the APP will be enrolled in an app based peer support program

Group II: CONTROLActive Control1 Intervention

In the control arm participants will receive existing standardized peer recovery support resources from SAMHSA

0 / 1Eligibility criteria met

Find a Location

Who is running the clinical trial?

National Institute on Drug Abuse (NIDA)NIH

2,469 Previous Clinical Trials

2,618,109 Total Patients Enrolled

National Institutes of Health (NIH)NIH

2,700 Previous Clinical Trials

7,505,576 Total Patients Enrolled

Indiana UniversityOTHER

980 Previous Clinical Trials

981,976 Total Patients Enrolled

Media Library

Mobile Phone App Clinical Trial Eligibility Overview. Trial Name: NCT05405712 — N/A

Opioid Use Disorder Research Study Groups: CONTROL, Marigold APP

Opioid Use Disorder Clinical Trial 2023: Mobile Phone App Highlights & Side Effects. Trial Name: NCT05405712 — N/A

Mobile Phone App 2023 Treatment Timeline for Medical Study. Trial Name: NCT05405712 — N/A

Opioid Use Disorder Patient Testimony for trial: Trial Name: NCT05405712 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

How many participants are currently recruited for this trial?

"Affirmative. Clinicaltrials.gov attests that this clinical study, which was initially posted on May 12th 2022, is presently recruiting participants. Approximately 1300 individuals must be enrolled from 2 separate medical centres."

Answered by AI

Are recruitment efforts for this research initiative still ongoing?

"Affirmative. Clinicaltrials.gov reveals that this trial is in the process of recruiting patients; it was initially posted on May 12th 2022 and updated most recently on October 28th 2022. The research team seeks a total of 1300 participants from two medical facilities."

Answered by AI